METROPOLIS - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.5
| Stock Code | METROPOLIS | Market Cap | 9,829 Cr. | Current Price | 1,895 ₹ | High / Low | 2,263 ₹ |
| Stock P/E | 73.6 | Book Value | 256 ₹ | Dividend Yield | 0.21 % | ROCE | 13.4 % |
| ROE | 10.5 % | Face Value | 2.00 ₹ | DMA 50 | 1,912 ₹ | DMA 200 | 1,921 ₹ |
| Chg in FII Hold | -0.84 % | Chg in DII Hold | 1.63 % | PAT Qtr | 46.6 Cr. | PAT Prev Qtr | 35.6 Cr. |
| RSI | 51.4 | MACD | -11.8 | Volume | 43,682 | Avg Vol 1Wk | 41,037 |
| Low price | 1,315 ₹ | High price | 2,263 ₹ | PEG Ratio | -5.27 | Debt to equity | 0.11 |
| 52w Index | 61.2 % | Qtr Profit Var | 10.3 % | EPS | 25.8 ₹ | Industry PE | 35.2 |
📊 Analysis: Metropolis Healthcare is trading at 1,895 ₹, slightly below its 50 DMA (1,912 ₹) and 200 DMA (1,921 ₹), indicating short-term weakness. RSI at 51.4 suggests neutral momentum, while MACD (-11.8) reflects bearish sentiment. Intraday volume (43.6k) is slightly above the weekly average (41k), showing stable participation. Fundamentals are mixed—EPS at 25.8 ₹ and PAT growth (+10.3%) support the stock, but high P/E (73.6 vs industry 35.2) and weak ROE (10.5%) limit valuation comfort.
💰 Optimal Buy Price (Intraday): 1,885–1,895 ₹ (near support zone).
📈 Profit-Taking Levels: 1,915 ₹ (first resistance), 1,935 ₹ (secondary resistance).
⚠️ Stop-Loss / Loss Protection: 1,870 ₹ (below intraday support).
⏱️ If Already Holding: Exit if price fails to sustain above 1,915 ₹ with volume confirmation or if RSI dips below 49 intraday. Hold for extended gains only if momentum sustains above 1,935 ₹ with strong volume recovery.
Positive
- 📈 EPS at 25.8 ₹ supports earnings base.
- 📊 PAT growth (46.6 Cr. vs 35.6 Cr., +10.3%).
- 📉 Debt-to-equity at 0.11, low leverage.
- 📈 DII holdings increased (+1.63%).
Limitation
- ⚠️ Current price below both 50 DMA and 200 DMA.
- 📉 MACD (-11.8) indicates bearish momentum.
- 📊 High P/E (73.6) vs industry average (35.2).
- 📉 PEG ratio (-5.27) suggests poor growth valuation.
Company Negative News
- 📉 FII holdings decreased (-0.84%).
- ⚠️ Stock trading far below recent high (2,263 ₹).
Company Positive News
- 📈 PAT growth quarter-on-quarter supports sentiment.
- 📊 DII accumulation (+1.63%) adds stability.
Industry
- 🏥 Diagnostics/healthcare sector PE at 35.2, Metropolis trades at a steep premium (73.6).
- 📈 Sector supported by rising demand for preventive and specialized healthcare services.
Conclusion
⚖️ Metropolis Healthcare is a moderate intraday candidate. Buy near 1,885–1,895 ₹ with stop-loss at 1,870 ₹. Profit booking can be considered at 1,915–1,935 ₹. Momentum indicators suggest caution, as MACD remains bearish despite stable volume and PAT growth. Traders should rely on volume confirmation before holding beyond 1,935 ₹.
Would you like me to also prepare a peer benchmarking overlay comparing Metropolis with Dr. Lal PathLabs and Vijaya Diagnostic to highlight relative intraday strength in the diagnostics sector?